Mizuo Mifune
Overview
Explore the profile of Mizuo Mifune including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
475
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ito H, Antoku S, Mori T, Nakagawa Y, Mizoguchi K, Matsumoto S, et al.
Clin Nephrol
. 2017 Oct;
89(5):330-335.
PMID: 29057735
Aim: The association between cognitive function and clinical parameters of chronic kidney disease (CKD) was investigated in Japanese patients without overt dementia in a cross-sectional study. Materials And Methods: A...
2.
Ito H, Yamashita H, Nakashima M, Takaki A, Yukawa C, Matsumoto S, et al.
J Clin Med Res
. 2017 Mar;
9(4):366-373.
PMID: 28270898
Background: We aimed to study the association between urinary liver-type fatty acid-binding protein (L-FABP), a biomarker of tubulointerstitial injury, and the clinical characteristics of normoalbuminuric and albuminuric patients with type...
3.
Ito H, Antoku S, Abe M, Omoto T, Shinozaki M, Nishio S, et al.
Intern Med
. 2016 Nov;
55(22):3247-3256.
PMID: 27853065
Objective The effects of febuxostat therapy on hyperuricemia in patients with and without type 2 diabetes were compared in this retrospective observational study after pair-matching using the propensity scores. Methods...
4.
Ito H, Tsugami E, Ando S, Imai A, Matsumoto S, Omoto T, et al.
J Clin Med Res
. 2016 Sep;
8(10):710-4.
PMID: 27635175
Background: We investigated the trends in the clinical characteristics and prescriptions of type 2 diabetic patients with severe hypoglycemia because the prescription rate of antidiabetic agents has significantly changed recently....
5.
Ito H, Omoto T, Abe M, Matsumoto S, Shinozaki M, Nishio S, et al.
Geriatr Gerontol Int
. 2015 Dec;
17(1):24-30.
PMID: 26634299
Aims: The aim of the present study was to clarify the relationships between the duration of diabetes and the current statuses of diabetes in elderly (aged ≥65 years) patients with...
6.
Ito H, Nakashima M, Meguro K, Furukawa H, Yamashita H, Takaki A, et al.
J Diabetes Res
. 2015 Jun;
2015:728127.
PMID: 26064988
We aimed to clarify the usefulness of measuring the flow mediated dilatation (FMD) in patients with type 2 diabetes mellitus without and with coronary heart disease (CHD). The FMD was...
7.
Ito H, Abe M, Antoku S, Omoto T, Shinozaki M, Nishio S, et al.
Expert Opin Pharmacother
. 2014 Dec;
16(3):289-96.
PMID: 25529857
Objective: The clinical course > 6 months after the initiation of linagliptin in patients with type 2 diabetes was compared among the groups divided by their renal function. Methods: Two...
8.
Ito H, Takeuchi Y, Ishida H, Otawa A, Shibayama A, Antoku S, et al.
J Diabetes Investig
. 2014 May;
1(6):273-8.
PMID: 24843443
Unlabelled: Aims/Introduction: The present study investigated the frequency of mild anemia, which is not an indication of intensive therapy using drugs, in Japanese patients with type 2 diabetes mellitus and...
9.
Ito H, Abe M, Antoku S, Omoto T, Shinozaki M, Nishio S, et al.
Drug Des Devel Ther
. 2014 May;
8:391-6.
PMID: 24790413
Background: The effects of switching from prandial premixed insulin therapy (PPT) injected three times a day to basal plus two times bolus insulin therapy (B2B) on glycemic control and quality...
10.
Ito H, Ohira H, Chinen T, Omoto T, Shinozaki M, Nishio S, et al.
Diabetes Care
. 2013 Dec;
37(1):e7-8.
PMID: 24356609
No abstract available.